You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TITER ON CHIP ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
SBC: INDEVR, INC. Topic: NIAIDDESCRIPTION provided by applicant It is widely acknowledged that for split vaccines potency determination is often a rate limiting step The FDA approved andquot gold standardandquot potency assay for influenza hemagglutinin HA protein based vaccines is single radial immunodiffusion SRID SRID is a time and labor intensive assay often requiring days to complete and a minimum of hou ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Low Cost Multi-pathogen Laser Diagnostic for HIV and AIDS Co-Infections
SBC: Precision Photonics Corporation Topic: N/ADESCRIPTION (provided by applicant): Diagnosis and medical management of HIV-infected individuals is significantly enhanced if one can simultaneously define the subset of the most common co-infections for which patients are at risk. Unfortunately, running such a series of parallel diagnostic tests is cost prohibitive, particularly in low-resource settings. Precision Photonics Corporation proposes ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Photoacoustic CT for Preclinical Molecular Imaging
SBC: OPTOSONICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The long-term objective of this collaborative research project is to commercialize a prototype photoacoustic computed-tomography (PCT) scanner for conducting preclinical molecular imaging. This scanner has been developed by OptoSonics with funding from a Fast Track SBIR grant from the National Cancer Institute (R44-CA-102891) and additional private funding fro ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Clinical Development of Combination Plague/Smallpox Vaccine
SBC: INVIRAGEN, LLC Topic: N/ADESCRIPTION (provided by applicant): The threat of terrorist attacks using biological weapons continues to be a major national security issue. A new congressional report (www.preventwmd.gov, Dec 3, 2008) indicates that a terrorist attack with bioweapons or other weapons of mass destruction might occur before 2013. Plague and smallpox could be devastating bioweapons if intentionally released. A rel ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Gene Based Therapy for Congestive Heart Failure P2 SBIR
SBC: Nanocor Therapeutics, Inc. Topic: NHLBIDESCRIPTION (provided by applicant): Congestive heart failure is a major cause of morbidity and mortality in the United States. While progress in conventional treatments is making steady and incremental gains to reduce heart failure mortality, there is a critical need to explore new therapeutic approaches. It is now apparent that gene therapy has broader potential in diseases such as congestive he ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Peptide-coated skin substitutes for the treatment of burn injuries and wounds
SBC: AFFINERGY, LLC Topic: 300DESCRIPTION provided by applicant Burn injuries and chronic wounds present a significant burden to patients and the US healthcare system Each year in the US there are burns that require medical treatment and burn patients that require hospitalization The mortality rate associated with severe burns can be as high as with of patient deaths arising from infection In add ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
SBC: Immunext, Inc. Topic: NIAIDDESCRIPTION provided by applicant Systemic lupus erythematosus SLE is a devastating autoimmune disease that most commonly affects women in their child bearing years SLE attacks multiple organ systems but renal and neurologic involvement are the usual harbingers of poor outcome Despite effective albeit toxic immunosuppressive therapy only of patients with these serious manifestations ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Self Assembling High Affinity Peptides for Point of Care Drug-Device Combinations
SBC: AFFINERGY, LLC Topic: N/ADESCRIPTION (provided by applicant): Infection surrounding metal implants is a common and sometimes devastating cause of implant failure in a number of fields including oral, craniomaxillofacial (CMF), orthopedic, and cardiovascular surgery. These infections, which arise from the establishment of biofilms on device surfaces, not only necessitate new surgeries but in themselves present a significan ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Commercialization of Human Mesothelial Cells for Research
SBC: Zen-Bio, Inc. Topic: N/ADESCRIPTION (provided by applicant): Mesothelial cells have been found to be pivotal in tumor metastasis, peritoneal dialysis, and inflammatory response. These cells are specialized epithelial cells that line the peritoneal, pericardial, and pleural cavities and internal organs presenting a barrier to invading organisms and physical damage. Ovarian tumor attachments occur through cancer cells bind ...
SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health -
Novel therapeutics for fatty liver disease and type-II diabetes
SBC: SOUTHEAST TECHINVENTURES INC Topic: 200DESCRIPTION provided by applicant Western lifestyle and diet have spurred the growth of numerous obesity related disorders in the US including metabolic syndrome and type diabetes to epidemic proportions However less well known is the rising epidemic of non alcoholic fatty liver disease NAFLD NAFLD ranges from mild hepatosteatosis to severe fibrosis or cirrhosis and is initially charac ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health